Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 1 Interventional Accepts healthy volunteers

A Study To Evaluate ASN002 In Subjects With Atopic Dermatitis

ClinicalTrials.gov ID: NCT03139981

Public ClinicalTrials.gov record NCT03139981. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jun 27, 2026, 12:05 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double -Blind, Placebo-Controlled, Sequential, Multiple-Dose Escalation Study To Evaluate The Safety, Tolerability, Pharmacokinetics And Preliminary Efficacy Of ASN002 In Subjects With Moderate-To-Severe Atopic Dermatitis

Study identification

NCT ID
NCT03139981
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1
Lead sponsor
Asana BioSciences
Industry
Enrollment
36 participants

Conditions and interventions

Interventions

  • ASN002 Drug
  • Placebo Oral Tablet Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 11, 2017
Primary completion
Nov 4, 2017
Completion
Dec 4, 2017
Last update posted
May 9, 2023

2017

United States locations

U.S. sites
9
U.S. states
5
U.S. cities
8
Facility City State ZIP Site status
Center for Dermatology Clinical Research, Inc. Fremont California 94538
Dermatology Research Associates Los Angeles California 30045
TCR Medical Corporation San Diego California 92123
Olympian Clinical Research Tampa Florida 33609
Forward Clinical Trials, Inc. Tampa Florida 33624
Dermatology Specialists Research Louisville Kentucky 40241
Center for Clinical Studies, Ltd., LLP Houston Texas 77004
Progressive Clinical Research, P.A. San Antonio Texas 78229
Virginia Clinical Research, Inc. Norfolk Virginia 23507

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03139981, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 9, 2023 · Synced Jun 27, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03139981 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →